68Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
India
Neuroscience Intelligence
India neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #22 of 50 · Data maturity A · Research score 38.1 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:34 UTC.
17Recruiting trials
235Publications
225Institutions
Executive interpretation
India ranks #22 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.70 recruiting
All India Institute of Medical Sciences, Bhubaneswar41 recruiting
All India Institute of Medical Sciences31 recruiting
GlaxoSmithKline30 recruiting
Newron Pharmaceuticals SPA20 recruiting
Bayer22 recruiting
Hoffmann-La Roche21 recruiting
Boehringer Ingelheim20 recruiting
Eli Lilly and Company21 recruiting
Neurovalens Ltd.20 recruiting
Disease activity
Epilepsy13trials
Parkinsons6trials
Depression4trials
Pain Neuropathy4trials
Alzheimers4trials
Bipolar Disorder3trials
Schizophrenia3trials
Stroke3trials
Migraine Headache3trials
Anxiety2trials
Research institutions
University of AllahabadOpenAlexlinked institution
Jain Irrigation Systems (India)OpenAlexlinked institution
Indraprastha Institute of Information Technology DelhiOpenAlexlinked institution
Panjab UniversityOpenAlexlinked institution
JSS Academy of Higher Education and ResearchOpenAlexlinked institution
Lady Hardinge Medical CollegeOpenAlexlinked institution
Shushrusha Citizens' Co-operative HospitalOpenAlexlinked institution
Institute of Medical SciencesOpenAlexlinked institution
Indian Institute of Management BangaloreOpenAlexlinked institution
Jawaharlal Institute of Post Graduate Medical Education and ResearchOpenAlexlinked institution
Clinical evidence trail
NCT07797725Efficacy of Low Glycemic Index Diet vs Modified Atkins Diet and Gluten Free Casein Free Diet as add-on Therapy With Standard of Care in Children With Autism Spectrum DisorderNOT_YET_RECRUITING
NCT07743814EFFECT OF ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) OF PRIMARY MOTOR CORTEX ON HEADACHE FREQUENCY IN PATIENTS WITH CHRONIC MIGRAINENOT_YET_RECRUITING
NCT07582380National Institute for Health and Care Research Global Health Research Centre for Multiple Long-Term ConditionsNOT_YET_RECRUITING
NCT07282743Efficacy and Safety of GL0034 in Overweight or Obese Adults With Type II Diabetes MellitusRECRUITING
NCT07251218Assessing the Effects of Cool Roofs on Mental Health in Ahmedabad, IndiaACTIVE_NOT_RECRUITING
NCT07131813Evaluation of Efficacy and Safety of add-on Tofacitinib in Patients With Oral Lichen PlanusRECRUITING
NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)RECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
NCT06744920A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia GravisRECRUITING
NCT05980949Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)RECRUITING
NCT05567796A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightACTIVE_NOT_RECRUITING
Research evidence trail
PUBMEDAuNP decorated-Ni-MOF nanosheet based cDNA sensor for detection of miRNA-128 in Alzheimer's disease.2027-02-01
PUBMEDA transdiagnostic evaluation of adult temperamental profiles and their interactions with childhood adversities across major psychiatric disorder.2026-12-15
PUBMEDGaze fixation stability is a transdiagnostic marker of major psychiatric disorders: A high-density family-based study.2026-12-01
PUBMEDTinyDINO VHaar based Bi-directional Chameleon optimized LightASDNet for autism spectrum disorder detection.2026-12-01
PUBMEDExploring toothpaste ingredients as potential chemical kindling agents in neuropsychiatric disorders: An adult zebrafish (Danio rerio) study.2026-12-01
PUBMEDTargeting glioblastoma epigenetics: mechanisms, microenvironmental interplay, and therapeutic potential.2026-11-03
PUBMEDAlcohol-induced dysregulation of tau and acetylation pathways in the pathogenesis of Alzheimer's disease.2026-11-03
PUBMEDIntranasal ketamine attenuates neuronal damage and behavioral deficits following mild fluid percussion injury.2026-11-01
PUBMEDCytochrome P450-mediated vitamin D and cholesterol metabolism in the pathophysiology of neurodevelopmental disorders.2026-11-01
PUBMEDBroader autism phenotype, the default mode network, and brain entropy: A network-level hypothesis.2026-11-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.